(Approval lapsed) SANDOZ ESTRADIOL DERM 75 estradiol hemihydrate transdermal therapeutic system (Canada)
Section 19A approved medicine
(Approval lapsed) SANDOZ ESTRADIOL DERM 75 estradiol hemihydrate transdermal therapeutic system (Canada)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
ESTRADOT 75 estradiol 75 microgram transdermal drug delivery system sachet - ARTG 338059
Indication(s)
Short term treatment of symptoms of estrogen deficiency due to the menopause, whether natural or surgically induced. In women with an intact uterus, estrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.
Images
